Florida Society of Clinical Oncology (FLASCO) Great Strides Together & Rapid Integrations 2026

Florida Society of Clinical Oncology (FLASCO) Great Strides Together & Rapid Integrations 2026 is organized by Florida Society of Clinical Oncology (FLASCO) and will be held from May 15 - 16, 2026 at Renaissance Orlando Resort – Disney Springs® Area, Lake Buena Vista, Florida, United States of America.

Description:
This activity addresses evolving clinical practice gaps across the oncology continuum, including oncologic emergencies, advanced imaging interpretation, management of bone and liver lesions, immunotherapy toxicities, cellular therapies, cardio-oncology, theranostics, and ctDNA integration. Through expert-led presentations and multidisciplinary panel discussions, participants will strengthen diagnostic confidence, enhance therapeutic decision-making, and improve coordination of care in complex oncology settings.

The program supports both experienced oncology providers and advanced practice providers seeking to build foundational knowledge and clinical confidence. Emphasis is placed on evidence-based practice, multidisciplinary collaboration, and patient-centered strategies that improve safety, outcomes, and quality of care.

The program is structured to support both experienced oncology providers and advanced practice providers seeking to build foundational clinical confidence.

Learning Objectives:
Upon completion of this activity, participants will be able to:

• Apply evidence-based clinical guidelines to the evaluation and management of oncologic emergencies and incidental imaging findings in oncology practice.
• Integrate multidisciplinary assessment strategies in the diagnosis and management of bone and liver lesions to improve clinical decision-making.
• Evaluate emerging oncology therapies, including immunotherapy and cellular therapies, and implement appropriate toxicity monitoring and management strategies.
• Incorporate advanced diagnostic tools, including circulating tumor DNA (ctDNA) and theranostics, into personalized cancer treatment planning.
• Identify and manage cardiovascular and other systemic complications associated with cancer therapies to enhance patient safety.
• Implement collaborative, team-based care approaches that improve treatment coordination, medication safety, and patient-centered outcomes across the cancer continuum.